Maura Casciola

Maura Casciola

Auto-generated profile, based on publicly available information

Maura Casciola

Office of Science and Engineering Laboratories Center for Devices and Radiological Health, US Food and Drug Administration Silver Spring Maryland USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2021 in Physiological Reports
Verified
Journal Article
Open access
PDF file
TFTromondae K. Feaster
Tromondae K. Feaster
MCMaura Casciola
Maura Casciola
ANAkshay Narkar
Akshay Narkar
KBKsenia Blinova
Ksenia Blinova
HiPSC-CMs’ contractility increases in response to biphasic nonexcitatory electrical pulses delivered during refractory period mimicking clinical CCM device therapy. CCM-induced inotropic effects to b...

27 October 2022 in Physiological Reports
Verified
Journal Article
Open access
MCMaura Casciola
Maura Casciola
DKDevin Keck
Devin Keck
TFTromondae K. Feaster
Tromondae K. Feaster
KBKsenia Blinova
Ksenia Blinova
Pulse electric field‐based (PEF) ablation is a technique whereby short high‐intensity electric fields inducing irreversible electroporation (IRE) are applied to various tissues. Here, we implemented a standardized in vitro model to compare the effects of biphasic symmetrical pulses (100 pulses, 1–10 μs phase duration (d), 10–1000 Hz pulse repetition rate (f)) using two different human cellular models: human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) and human esophageal smooth muscle cells (hESMCs) cultured in monolayer format. We report the PEF‐induced irreversibly electroporated cell monolayer areas and the corresponding electric field thresholds (EFTs) for both cardiac and esophageal cultures. Our results suggest marked cell type specificity with EFT estimated to be 2–2.5 times lower in hiPSC‐CMs than in hESMCs when subjected to identical PEF treatments (e.g., 0.90 vs 1.85 kV/cm for the treatment of 100 pulses with d = 5 μs, f = 10 Hz, and 0.65 vs 1.67 kV/cm for the treatment of 100 pulses with d = 10 μs, f = 10 Hz). PEF treatment can result in increased temperature around the stimulating electrodes and lead to unanticipated thermal tissue damage that is proportional to the peak temperature rise and to the duration of the PEF‐induced elevated temperatures. In our study, temperature increases ranged from less than 1°C to as high as 30°C, however, all temperature changes were transient and quickly returned to baseline and the highest observed ∆T returned to 50% of its maximum recorded temperature in tens of seconds.

2 November 2022 in Physiological Reports
Verified
Journal Article
Open access
ANAkshay Narkar
Akshay Narkar
TFTromondae K. Feaster
Tromondae K. Feaster
MCMaura Casciola
Maura Casciola
KBKsenia Blinova
Ksenia Blinova
Two of the most prominent organ systems, the nervous and the cardiovascular systems, are intricately connected to maintain homeostasis in mammals. Recent years have shown tremendous efforts toward therapeutic modulation of cardiac contractility and electrophysiology by electrical stimulation. Neuronal innervation and cardiac ganglia regulation are often overlooked when developing in vitro models for cardiac devices, but it is likely that peripheral nervous system plays a role in the clinical effects. We developed an in vitro neurocardiac coculture (ivNCC) model system to study cardiac and neuronal interplay using human induced pluripotent stem cell (hiPSC) technology. We demonstrated significant expression and colocalization of cardiac markers including troponin, α‐actinin, and neuronal marker peripherin in neurocardiac coculture. To assess functional coupling between the cardiomyocytes and neurons, we evaluated nicotine‐induced β‐adrenergic norepinephrine effect and found beat rate was significantly increased in ivNCC as compared to monoculture alone. The developed platform was used as a nonclinical model for the assessment of cardiac medical devices that deliver nonexcitatory electrical pulses to the heart during the absolute refractory period of the cardiac cycle, that is, cardiac contractility modulation (CCM) therapy. Robust coculture response was observed at 14 V/cm (5 V, 64 mA), monophasic, 2 ms pulse duration for pacing and 20 V/cm (7 V, 90 mA) phase amplitude, biphasic, 5.14 ms pulse duration for CCM. We observed that the CCM effect and kinetics were more pronounced in coculture as compared to cardiac monoculture, supporting a hypothesis that some part of CCM mechanism of action can be attributed to peripheral nervous system stimulation. This study provides novel characterization of CCM effects on hiPSC‐derived neurocardiac cocultures. This innervated human heart model can be further extended to investigate arrhythmic mechanisms, neurocardiac safety, and toxicity post‐chronic exposure to materials, drugs, and medical devices. We present data on acute CCM electrical stimulation effects on a functional and optimized coculture using commercially available hiPSC‐derived cardiomyocytes and neurons. Moreover, this study provides an in vitro human heart model to evaluate neuronal innervation and cardiac ganglia regulation of contractility by applying CCM pulse parameters that closely resemble clinical setting. This ivNCC platform provides a potential tool for investigating aspects of cardiac and neurological device safety and performance.

3 March 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
TFTromondae K. Feaster
Tromondae K. Feaster
JEJourdan Ewoldt
Jourdan Ewoldt
AAAnna Avila
Anna Avila
MCMaura Casciola
Maura Casciola
ANAkshay Narkar
Akshay Narkar
KBKsenia Blinova
Ksenia Blinova
Introduction: Cardiac contractility modulation (CCM) is a medical device‐based therapy delivering non‐excitatory electrical stimulations to the heart to enhance cardiac function in heart failure (HF) patients. The lack of human in vitro tools to assess CCM hinders our understanding of CCM mechanisms of action. Here, we introduce a novel chronic (i.e., 2‐day) in vitro CCM assay to evaluate the effects of CCM in a human 3D microphysiological system consisting of engineered cardiac tissues (ECTs).Methods: Cryopreserved human induced pluripotent stem cell‐derived cardiomyocytes were used to generate 3D ECTs. The ECTs were cultured, incorporating human primary ventricular cardiac fibroblasts and a fibrin‐based gel. Electrical stimulation was applied using two separate pulse generators for the CCM group and control group. Contractile properties and intracellular calcium were measured, and a cardiac gene quantitative PCR screen was conducted.Results: Chronic CCM increased contraction amplitude and duration, enhanced intracellular calcium transient amplitude, and altered gene expression related to HF (i.e., natriuretic peptide B, NPPB) and excitation‐contraction coupling (i.e., sodium‐calcium exchanger, SLC8).Conclusion: These data represent the first study of chronic CCM in a 3D ECT model, providing a nonclinical tool to assess the effects of cardiac electrophysiology medical device signals complementing in vivo animal studies. The methodology established a standardized 3D ECT‐based in vitro testbed for chronic CCM, allowing evaluation of physiological and molecular effects on human cardiac tissues.

1 August 2016 in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
Verified
Conference Paper
Closed access
ADA. Denzi
A. Denzi
CMCaterina Merla
Caterina Merla
MCM. Casciola
M. Casciola
James HwangJames Hwang
James Hwang
XCXuanhong Cheng
Xuanhong Cheng
MLMicaela Liberti
Micaela Liberti
In the last decades, the advances in the micro and nano fabrication techniques have led to the development of microdevices that improved the possibility of analysis at cell level. These devices can be used in different applications (e.g., cell detection and identification, manipulation, cell treatments). The requisites, that are necessary to achieve, are different for various applications and represent the starting point of the project. The numerical multiphysics models can be very advantageous to analyze the performances of such devices and to predict their operation. Aim of this work is to give a look of the design rules of microchamber devices in particular for their application in electric field exposure. Two different applications for cell discrimination and characterization are reported considering time and frequency domain measurements.

1 June 2016
Verified
Conference Paper
Closed access
MCMaura Casciola
Maura Casciola
MLMicaela Liberti
Micaela Liberti
FAFrancesca Apollonio
Francesca Apollonio
ADAgnese Denzi
Agnese Denzi
The emergence of nanosecond pulsed electric fields (nsPEFs) for intracellular electro-manipulation experiments implies the application of extremely short (ns) high intensity (MV/m) electric field pulses. Specific pulse generators and miniaturized applicators are necessary to properly deliver this category of voltage signals to biological loads. In this context, we propose the design of a versatile nsPEFs applicator, developed following the guidelines typical of microwave propagating systems. The designed microchamber is suitable for in vitro exposure to undistorted pulses with duration down to 1-3 ns during single and multi cell experiments. Further features are: high efficiency (above 0.95), high cell viability by the integration of microfluidic components, real time monitoring of the biological sample and of the pulse propagation. These features can be considered as designing rules for new nanosecond and sub-nanosecond applicators, to ensure experimental repeatability and reproducibility when the impact of propagation on pulse signals is no more negligible.